• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清层粘连蛋白测定在肝病和癌症患者中是否有应用价值?

Is there a place for serum laminin determination in patients with liver disease and cancer?

作者信息

Rosa Heitor, Parise Edison Roberto

机构信息

Unit of Gastroenterology and Hepatology, Federal University of Goias School of Medicine, Rua 126 n. 21, Setor Sul, Goiania, Goias 74093-080, Brazil.

出版信息

World J Gastroenterol. 2008 Jun 21;14(23):3628-32. doi: 10.3748/wjg.14.3628.

DOI:10.3748/wjg.14.3628
PMID:18595129
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2719225/
Abstract

Laminin is a glycoprotein which has an important role in the mechanism of fibrogenesis and is, thus, related to hepatic fibrosis in addition to presenting increased levels in several types of neoplasias. However, its determination is not routinely considered in the study of hepatic fibrosis. In this review, the authors critically comment on the role of this glycoprotein compared to other markers of fibrosis through non-invasive procedures (Fibroscan). They also consider its clinical investigational potential and believe that the continuation of these investigations might contribute to a better understanding of the fibrogenic mechanism, which could in turn either lead to the identification of patients at risk of developing fibrosis non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) or at least be used as an indicator for hepatic biopsy in such patients. Finally, the authors believe that serum laminin determination might contribute to the diagnosis of epithelial tumor metastasis and peritoneal carcinomatosis.

摘要

层粘连蛋白是一种糖蛋白,在纤维生成机制中起重要作用,因此,除了在几种类型的肿瘤中水平升高外,还与肝纤维化有关。然而,在肝纤维化研究中,通常不考虑对其进行测定。在这篇综述中,作者通过非侵入性程序(Fibroscan),批判性地评论了这种糖蛋白与其他纤维化标志物相比的作用。他们还考虑了其临床研究潜力,并认为继续这些研究可能有助于更好地理解纤维生成机制,这反过来可能导致识别有发展为非酒精性脂肪性肝病(NAFLD)和非酒精性脂肪性肝炎(NASH)纤维化风险的患者,或者至少用作此类患者肝活检的指标。最后,作者认为血清层粘连蛋白测定可能有助于上皮肿瘤转移和腹膜癌病的诊断。

相似文献

1
Is there a place for serum laminin determination in patients with liver disease and cancer?血清层粘连蛋白测定在肝病和癌症患者中是否有应用价值?
World J Gastroenterol. 2008 Jun 21;14(23):3628-32. doi: 10.3748/wjg.14.3628.
2
Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease.血清层粘连蛋白、IV型胶原和透明质酸作为非酒精性脂肪性肝病的纤维化标志物
Braz J Med Biol Res. 2005 May;38(5):747-53. doi: 10.1590/s0100-879x2005000500012. Epub 2005 May 25.
3
Characteristics and diagnosis of NAFLD/NASH.非酒精性脂肪性肝病/非酒精性脂肪性肝炎的特征和诊断。
J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:64-70. doi: 10.1111/jgh.12271.
4
Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease.非酒精性脂肪性肝病诊断和监测的无创性生物标志物研究进展。
Metabolism. 2020 Oct;111S:154259. doi: 10.1016/j.metabol.2020.154259. Epub 2020 May 5.
5
[Clinical significance of measurement of PIIIP, laminin P1, type IV-C and 7S in patients with chronic liver diseases--with special reference to histological findings].
Nihon Shokakibyo Gakkai Zasshi. 1992 Sep;89(9):2007-15.
6
Decreased immunoexpression of survivin could be a potential marker in human non-alcoholic fatty liver disease progression?存活素免疫表达降低可能是非酒精性脂肪性肝病进展的一个潜在标志物?
Liver Int. 2011 Mar;31(3):377-85. doi: 10.1111/j.1478-3231.2010.02370.x. Epub 2010 Nov 26.
7
The Relevance of Noninvasive Tools To Assess Fibrosis in Non-Alcoholic Fatty Liver Disease.非酒精性脂肪性肝病纤维化无创评估工具的相关性。
Curr Pharm Des. 2020;26(32):3928-3938. doi: 10.2174/1381612826666200521133307.
8
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.分子机制:非酒精性脂肪性肝病、脂肪性肝炎和肝细胞癌之间的联系。
Int J Mol Sci. 2020 Feb 23;21(4):1525. doi: 10.3390/ijms21041525.
9
Biochemical markers of hepatic fibrosis.肝纤维化的生化标志物。
Clin Biochem. 1991 Jun;24(3):219-39. doi: 10.1016/0009-9120(91)80013-s.
10
Serum type IV collagen in various liver diseases in comparison with serum 7S collagen, laminin, and type III procollagen peptide.各种肝脏疾病中血清IV型胶原蛋白与血清7S胶原蛋白、层粘连蛋白和III型前胶原肽的比较
J Gastroenterol. 1996 Apr;31(2):242-8. doi: 10.1007/BF02389524.

引用本文的文献

1
Single and multi-omic characterization of a porcine model of ethanol-induced hepatic fibrosis.乙醇诱导的肝纤维化猪模型的单组学和多组学特征分析
Epigenetics. 2025 Dec;20(1):2471127. doi: 10.1080/15592294.2025.2471127. Epub 2025 Mar 4.
2
Clinical importance of laboratory biomarkers in liver fibrosis.实验室生物标志物在肝纤维化中的临床重要性。
Biochem Med (Zagreb). 2022 Oct 1;32(3):030501. doi: 10.11613/BM.2022.030501.
3
The Use of Antifibrotic Recombinant nAG Protein in a Rat Liver Fibrosis Model.抗纤维化重组 nAG 蛋白在大鼠肝纤维化模型中的应用。
Biomed Res Int. 2019 Jun 2;2019:9846919. doi: 10.1155/2019/9846919. eCollection 2019.
4
Diagnostic accuracy of glycoproteins in the assessment of liver fibrosis: A comparison between laminin, fibronectin, and hyaluronic acid.糖蛋白在肝纤维化评估中的诊断准确性:层粘连蛋白、纤连蛋白和透明质酸之间的比较
Turk J Gastroenterol. 2019 Jun;30(6):524-531. doi: 10.5152/tjg.2019.17339.
5
Esophageal Cancer in Golestan Province, Iran: A Review of Genetic Susceptibility and Environmental Risk Factors.伊朗戈勒斯坦省的食管癌:遗传易感性与环境危险因素综述
Middle East J Dig Dis. 2016 Oct;8(4):249-266. doi: 10.15171/mejdd.2016.34.
6
Integrin β1 regulates leiomyoma cytoskeletal integrity and growth.整合素 β1 调节子宫肌瘤细胞骨架的完整性和生长。
Matrix Biol. 2012 Sep-Oct;31(7-8):389-97. doi: 10.1016/j.matbio.2012.09.005. Epub 2012 Sep 26.
7
Helicobacter pylori AlpA and AlpB bind host laminin and influence gastric inflammation in gerbils.幽门螺杆菌 AlpA 和 AlpB 结合宿主层粘连蛋白并影响沙鼠的胃炎症。
Infect Immun. 2011 Aug;79(8):3106-16. doi: 10.1128/IAI.01275-10. Epub 2011 May 16.
8
Decreased collagen types I and IV, laminin, CK-19 and α-SMA expression after bone marrow cell transplantation in rats with liver fibrosis.骨髓细胞移植治疗肝纤维化大鼠后胶原 I 型和 IV 型、层粘连蛋白、细胞角蛋白 19 和 α-SMA 表达降低。
Histochem Cell Biol. 2010 Nov;134(5):493-502. doi: 10.1007/s00418-010-0746-2. Epub 2010 Oct 21.
9
Non-invasive assessment of liver fibrosis in chronic liver diseases: implementation in clinical practice and decisional algorithms.慢性肝病肝纤维化的无创评估:临床实践中的应用及决策算法
World J Gastroenterol. 2009 May 14;15(18):2190-203. doi: 10.3748/wjg.15.2190.

本文引用的文献

1
Clinical significance of changes in tumor markers, extracellular matrix, MMP-9 and VEGF in patients with gastric carcinoma.胃癌患者肿瘤标志物、细胞外基质、基质金属蛋白酶-9和血管内皮生长因子变化的临床意义
Hepatogastroenterology. 2007 Jul-Aug;54(77):1591-5.
2
Evaluation of serum procollagen aminoterminal propeptide III, laminin, and hydroxyproline as predictors of severe fibrosis in patients with chronic hepatitis C.评估血清Ⅲ型前胶原氨基端前肽、层粘连蛋白和羟脯氨酸作为慢性丙型肝炎患者严重纤维化预测指标的价值。
J Immunoassay Immunochem. 2007;28(3):199-211. doi: 10.1080/15321810701454649.
3
Serum hyaluronan and laminin level in children with chronic hepatitis B during long-term lamivudine treatment.长期拉米夫定治疗慢性乙型肝炎患儿血清透明质酸和层粘连蛋白水平
Hepatogastroenterology. 2007 Apr-May;54(75):834-8.
4
Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.肝纤维化的生物标志物:分子发病机制的临床转化还是基于肝脏相关功能异常检测
Clin Chim Acta. 2007 Jun;381(2):107-13. doi: 10.1016/j.cca.2007.02.038. Epub 2007 Feb 27.
5
Noninvasive evaluation of hepatic fibrosis in children with infant hepatitis syndrome.婴儿肝炎综合征患儿肝纤维化的无创评估
World J Gastroenterol. 2006 Nov 28;12(44):7155-60. doi: 10.3748/wjg.v12.i44.7155.
6
Non-invasive markers to predict the liver fibrosis in non-alcoholic fatty liver disease.预测非酒精性脂肪性肝病肝纤维化的非侵入性标志物。
Liver Int. 2006 Sep;26(7):864-71. doi: 10.1111/j.1478-3231.2006.01312.x.
7
Laminin gamma2-chain fragment circulating level increases in patients with metastatic pancreatic ductal cell adenocarcinomas.层粘连蛋白γ2链片段的循环水平在转移性胰腺导管细胞腺癌患者中升高。
Cancer Lett. 2005 Jul 8;225(1):167-76. doi: 10.1016/j.canlet.2004.11.052. Epub 2005 Jan 18.
8
Serum laminin, type IV collagen and hyaluronan as fibrosis markers in non-alcoholic fatty liver disease.血清层粘连蛋白、IV型胶原和透明质酸作为非酒精性脂肪性肝病的纤维化标志物
Braz J Med Biol Res. 2005 May;38(5):747-53. doi: 10.1590/s0100-879x2005000500012. Epub 2005 May 25.
9
Laminin concentration in ascites of patients with hepatic cirrhosis and peritoneal carcinomatosis.肝硬化和腹膜癌患者腹水中层粘连蛋白的浓度。
Braz J Med Biol Res. 2005 Feb;38(2):271-6. doi: 10.1590/s0100-879x2005000200016. Epub 2005 Feb 15.
10
Clinical usefulness of biochemical markers of liver fibrosis in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者肝纤维化生化标志物的临床应用价值
World J Gastroenterol. 2005 Jan 14;11(2):255-9. doi: 10.3748/wjg.v11.i2.255.